362 related articles for article (PubMed ID: 31138245)
1. Reliability and safety of minimally invasive esophagectomy after neoadjuvant chemoradiation: a retrospective study.
Liu G; Han Y; Peng L; Wang K; Fan Y
J Cardiothorac Surg; 2019 May; 14(1):97. PubMed ID: 31138245
[TBL] [Abstract][Full Text] [Related]
2. Morbidity and Mortality of Patients Who Underwent Minimally Invasive Esophagectomy After Neoadjuvant Chemoradiotherapy vs Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Randomized Clinical Trial.
Wang H; Tang H; Fang Y; Tan L; Yin J; Shen Y; Zeng Z; Zhu J; Hou Y; Du M; Jiao J; Jiang H; Gong L; Li Z; Liu J; Xie D; Li W; Lian C; Zhao Q; Chen C; Zheng B; Liao Y; Li K; Li H; Wu H; Dai L; Chen KN
JAMA Surg; 2021 May; 156(5):444-451. PubMed ID: 33729467
[TBL] [Abstract][Full Text] [Related]
3. CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT
Tang H; Tan L; Shen Y; Wang H; Lin M; Feng M; Xu S; Guo W; Qian C; Liu T; Zeng Z; Hou Y; Yu Z; Jiang H; Li Z; Chen C; Lian C; Du M; Li H; Xie D; Yin J; Zhao N; Wang Q
BMC Cancer; 2017 Jun; 17(1):450. PubMed ID: 28659128
[TBL] [Abstract][Full Text] [Related]
4. Outcomes With Open and Minimally Invasive Ivor Lewis Esophagectomy After Neoadjuvant Therapy.
Tapias LF; Mathisen DJ; Wright CD; Wain JC; Gaissert HA; Muniappan A; Lanuti M; Donahue DM; Morse CR
Ann Thorac Surg; 2016 Mar; 101(3):1097-103. PubMed ID: 26652140
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemotherapy followed by minimally invasive esophagectomy is safe and feasible for treatment of esophageal squamous cell carcinoma.
Ma S; Yan T; Liu D; Wang K; Wang J; Song J; Wang T; He W; Bai J; Jin L; Chen X
Thorac Cancer; 2018 Feb; 9(2):310-315. PubMed ID: 29319236
[TBL] [Abstract][Full Text] [Related]
6. Minimally invasive esophagectomy is safe and effective following neoadjuvant chemoradiation therapy.
Ben-David K; Rossidis G; Zlotecki RA; Grobmyer SR; Cendan JC; Sarosi GA; Hochwald SN
Ann Surg Oncol; 2011 Nov; 18(12):3324-9. PubMed ID: 21479689
[TBL] [Abstract][Full Text] [Related]
7. Comparisons between minimally invasive and open esophagectomy for esophageal cancer with cervical anastomosis: a retrospective study.
Li Z; Liu C; Liu Y; Yao S; Xu B; Dong G
J Cardiothorac Surg; 2020 Jun; 15(1):128. PubMed ID: 32513211
[TBL] [Abstract][Full Text] [Related]
8. Minimal invasive versus open esophagectomy for patients with esophageal squamous cell carcinoma after neoadjuvant treatments.
Chen D; Wang W; Mo J; Ren Q; Miao H; Chen Y; Wen Z
BMC Cancer; 2021 Feb; 21(1):145. PubMed ID: 33563244
[TBL] [Abstract][Full Text] [Related]
9. Concurrent radiotherapy cannot provide superiority of surgical oncological outcome and long-term survival rate in locally advanced esophageal squamous cell carcinoma patients receiving neoadjuvant chemotherapy followed by minimally invasive esophagectomy.
Wang YJ; Bao T; Li KK; Xie XF; He XD; Zhao XL; Guo W
Surg Endosc; 2023 Sep; 37(9):7073-7082. PubMed ID: 37380741
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of minimally invasive esophagectomy in esophageal cancer after neoadjuvant chemoradiotherapy.
Warner S; Chang YH; Paripati H; Ross H; Ashman J; Harold K; Day R; Stucky CC; Rule W; Jaroszewski D
Ann Thorac Surg; 2014 Feb; 97(2):439-45. PubMed ID: 24266955
[TBL] [Abstract][Full Text] [Related]
11. Incidence and impact of postoperative atrial fibrillation after minimally invasive esophagectomy.
Day RW; Jaroszewski D; Chang YH; Ross HJ; Paripati H; Ashman JB; Rule WG; Harold KL
Dis Esophagus; 2016 Aug; 29(6):583-8. PubMed ID: 25824527
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy followed by minimally invasive esophagectomy for locally advanced esophageal squamous cell carcinoma: a prospective multicenter randomized clinical trial.
Tang H; Wang H; Fang Y; Zhu JY; Yin J; Shen YX; Zeng ZC; Jiang DX; Hou YY; Du M; Lian CH; Zhao Q; Jiang HJ; Gong L; Li ZG; Liu J; Xie DY; Li WF; Chen C; Zheng B; Chen KN; Dai L; Liao YD; Li K; Li HC; Zhao NQ; Tan LJ
Ann Oncol; 2023 Feb; 34(2):163-172. PubMed ID: 36400384
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes of 530 esophageal squamous cell carcinoma patients with minimally invasive Ivor Lewis esophagectomy.
Qi W; Zixiang W; Tianwei Z; Shuai F; Sai Z; Gang S; Ming W
J Surg Oncol; 2018 Apr; 117(5):957-969. PubMed ID: 29878389
[TBL] [Abstract][Full Text] [Related]
14. Minimally Invasive Esophagectomy with Thoracic Duct Resection Post Neoadjuvant Chemoradiotherapy for Carcinoma Esophagus-Impact on Lymph Node Yield and Hemodynamic Parameters.
Anand S; Kalayarasan R; Chandrasekar S; Gnanasekaran S; Pottakkat B
J Gastrointest Cancer; 2019 Jun; 50(2):230-235. PubMed ID: 29344808
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant Anlotinib and chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced esophageal squamous cell carcinoma: Short-term results of an open-label, randomized, phase II trial.
Wang YJ; Li KK; Xie XF; Bao T; Hao ZP; Long J; Wang S; Zhong ZY; Guo W
Front Oncol; 2022; 12():908841. PubMed ID: 35982957
[TBL] [Abstract][Full Text] [Related]
16. Preoperative neutrophil-to-lymphocyte ratio predicts the prognosis of esophageal squamous cell cancer patients undergoing minimally invasive esophagectomy after neoadjuvant chemotherapy.
Kato T; Oshikiri T; Goto H; Urakawa N; Hasegawa H; Kanaji S; Yamashita K; Matsuda T; Nakamura T; Suzuki S; Kakeji Y
J Surg Oncol; 2021 Dec; 124(7):1022-1030. PubMed ID: 34460103
[TBL] [Abstract][Full Text] [Related]
17. Perioperative outcomes of neoadjuvant chemotherapy plus camrelizumab compared with chemotherapy alone and chemoradiotherapy for locally advanced esophageal squamous cell cancer.
Zhang B; Zhao H; Wu X; Gong L; Yang D; Li X; Chen X; Li J; Wang W; Wu J; Xiao Q
Front Immunol; 2023; 14():1066527. PubMed ID: 36825006
[TBL] [Abstract][Full Text] [Related]
18. The implementation of minimally-invasive esophagectomy does not impact short-term outcome in a high-volume center.
Schwameis K; Ba-Ssalamah A; Wrba F; Birner P; Prager G; Hejna M; Schmid R; Asari R; Zacherl J; Schoppmann SF
Anticancer Res; 2013 May; 33(5):2085-91. PubMed ID: 23645759
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant versus adjuvant chemoradiation for stage II-III esophageal squamous cell carcinoma: a single institution experience.
Chen Y; Hao D; Wu X; Xing W; Yang Y; He C; Wang W; Liu J; Wang J
Dis Esophagus; 2017 Jul; 30(7):1-7. PubMed ID: 28475725
[TBL] [Abstract][Full Text] [Related]
20. Impact of Interval Between Neoadjuvant Chemoradiation and Surgery Upon Morbidity and Survival of Patients with Squamous Cell Carcinoma of Thoracic Esophagus.
Furukawa T; Hamai Y; Hihara J; Emi M; Yamakita I; Ibuki Y; Kurokawa T; Okada M
Anticancer Res; 2018 Sep; 38(9):5239-5245. PubMed ID: 30194173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
